Sales: § 363 Developments
This session will cover recent approaches to sales, recent trends in sale cases, the roles of the various constituents in sale cases, biopharmaceutical sales, lease issues and much more.
Supreme Court Roundup
This panel of leading Supreme Court practitioners will discuss leading cases and different ways of viewing specific problems in bankruptcy vs. appellate courts.
Cross-Border Practice
This panel will discuss eligibility issues and strategies related to chapters 11 and 15, filing in other jurisdictions, and cases such as Modern Land, Global Cord Blood and Comair Ltd.
Ethics (2023 Views from the Bench)
This session will focus on conflict issues, getting retained and paid, and § 327/disclosure issues.
ABI-Live: SCOTUS Crossfire: Will Purdue Be the Last Mass Tort Bankruptcy?
The Supreme Court on Aug. 10 granted an emergency application for a stay and granted certiorari in the case of Harrington v. Purdue Pharma L.P. The Court will consider whether the Bankruptcy Code authorizes a court to approve, as part of a plan of reorganization under chapter 11 of the Bankruptcy Code, a release that extinguishes claims held by nondebtors against nondebtor third parties without the claimants’ consent. The case is scheduled to be argued in the December 2023 argument session. Hear experts on both sides of the issue as they prognosticate on how the use of third-party releases may unfold before the Supreme Court.
Forensic Panel
This panel will focus on cross-border financial crime in a restructuring setting, including FCPA or sanctions violations, valuation fraud and money laundering.